← all drugs
Quinapril/Hydrochlorothiazide Tablet
in shortage · Cardiovascular · Snapshot: 2026-10-09
Day 1,359
of this shortage, counting from the FDA's first posting on 01/19/2023
- Manufacturers listed
- Aurobindo Pharma USA, Chartwell Molecular Holdings LLC
- Reported reason(s)
- Discontinuation of the manufacture of the drug
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) | Aurobindo Pharma USA | Unavailable | 10/02/2026 |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90) | Aurobindo Pharma USA | Unavailable | 10/02/2026 |
| Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Chartwell Molecular Holdings LLC | Available | 10/02/2026 |
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Chartwell Molecular Holdings LLC | Available | 10/02/2026 |
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Chartwell Molecular Holdings LLC | Available | 10/02/2026 |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90) | Aurobindo Pharma USA | Unavailable | 10/02/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.